108 related articles for article (PubMed ID: 3056605)
1. Etoposide in recurrent childhood Langerhans' cell histiocytosis: an Italian cooperative study.
Ceci A; de Terlizzi M; Colella R; Balducci D; Toma MG; Zurlo MG; Macchia P; Mancini A; Indolfi P; Locurto M
Cancer; 1988 Dec; 62(12):2528-31. PubMed ID: 3056605
[TBL] [Abstract][Full Text] [Related]
2. Etoposide in the treatment of six children with Langerhans cell histiocytosis (histiocytosis X).
Viana MB; Oliveira BM; Silva CM; Rios Leite VH
Med Pediatr Oncol; 1991; 19(4):289-94. PubMed ID: 1669481
[TBL] [Abstract][Full Text] [Related]
3. Treatment of Langerhans cell histiocytosis in children with etoposide.
Ishii E; Matsuzaki A; Okamura J; Inoue T; Kajiwara M; Uozumi T; Yoshida N; Miyazaki S; Miyake K; Matsumoto T
Am J Clin Oncol; 1992 Dec; 15(6):515-7. PubMed ID: 1449115
[TBL] [Abstract][Full Text] [Related]
4. Risk of secondary leukemia after treatment with etoposide (VP-16) for Langerhans' cell histiocytosis in Italian and Austrian-German populations.
Haupt R; Fears TR; Heise A; Gadner H; Loiacono G; De Terlizzi M; Tucker MA
Int J Cancer; 1997 Mar; 71(1):9-13. PubMed ID: 9096658
[TBL] [Abstract][Full Text] [Related]
5. [Lenalidomide induced therapeutic response in a patient with aggressive multi-system Langerhans cell histiocytosis resistant to 2-chloro-deoxyadenosine and early relapsing after high-dose BEAM chemotherapy with autologous peripheral blood stem cell transplantation].
Adam Z; Rehák Z; Koukalová R; Szturz P; Krejčí M; Pour L; Zahradová L; Moulis M; Kodet R; Nebeský T; Brejcha M; Adamová Z; Hájek R; Mayer J
Vnitr Lek; 2012 Jan; 58(1):62-71. PubMed ID: 22448704
[TBL] [Abstract][Full Text] [Related]
6. Etoposide in Langerhans cell histiocytosis in children: a preliminary experience.
Basade MM; Nair CN; Kurkure PA; Pai SK; Advani SH
Pediatr Hematol Oncol; 1996; 13(2):159-62. PubMed ID: 8721030
[TBL] [Abstract][Full Text] [Related]
7. A case of malignant histiocytosis successfully treated with combination interferon and etoposide therapy.
Takemori H; Sakata Y; Suzuki H; Yamaya T; Furugori N; Morimoto S; Yoshida Y
Jpn J Clin Oncol; 1990 Dec; 20(4):431-5. PubMed ID: 2126576
[TBL] [Abstract][Full Text] [Related]
8. Etoposide (VP16) in the treatment of multisystem Langerhans cell histiocytosis (histiocytosis X).
Broadbent V; Pritchard J; Yeomans E
Med Pediatr Oncol; 1989; 17(2):97-100. PubMed ID: 2784842
[TBL] [Abstract][Full Text] [Related]
9. Langerhans cell sarcoma.
Ferringer T; Banks PM; Metcalf JS
Am J Dermatopathol; 2006 Feb; 28(1):36-9. PubMed ID: 16456323
[TBL] [Abstract][Full Text] [Related]
10. Successful treatment of multisystem Langerhans cell histiocytosis (histiocytosis X) with etoposide.
Yu LC; Shenoy S; Ward K; Warrier RP
Am J Pediatr Hematol Oncol; 1994 Aug; 16(3):275-7. PubMed ID: 8037350
[TBL] [Abstract][Full Text] [Related]
11. Langerhans' cell histiocytosis cells are activated Langerhans' cells.
Emile JF; Fraitag S; Leborgne M; de Prost Y; Brousse N
J Pathol; 1994 Oct; 174(2):71-6. PubMed ID: 7965409
[TBL] [Abstract][Full Text] [Related]
12. A randomized trial of treatment for multisystem Langerhans' cell histiocytosis.
Gadner H; Grois N; Arico M; Broadbent V; Ceci A; Jakobson A; Komp D; Michaelis J; Nicholson S; Pötschger U; Pritchard J; Ladisch S;
J Pediatr; 2001 May; 138(5):728-34. PubMed ID: 11343051
[TBL] [Abstract][Full Text] [Related]
13. Etoposide-based combination chemotherapy in malignant histiocytosis.
Lin FR; Yao EG
J Tongji Med Univ; 1994; 14(4):227-9. PubMed ID: 7760434
[TBL] [Abstract][Full Text] [Related]
14. Langerhans-cell histiocytosis--excellent response to etoposide.
Mayou SC; Chu AC; Munro DD; Plowman N
Clin Exp Dermatol; 1991 Jul; 16(4):292-4. PubMed ID: 1794174
[TBL] [Abstract][Full Text] [Related]
15. Inefficacy of cisplatin and etoposide as salvage therapy for children with recurrent or unresponsive soft tissue sarcoma.
Raney RB
Cancer Treat Rep; 1987 Apr; 71(4):407-8. PubMed ID: 3829015
[TBL] [Abstract][Full Text] [Related]
16. Clinical trial of etoposide (VP-16) in children with recurrent malignant solid tumors. A phase II study from the Pediatric Oncology Group.
Kung F; Hayes FA; Krischer J; Mahoney D; Leventhal B; Brodeur G; Berry DH; Dubowy R; Toledano S
Invest New Drugs; 1988 Apr; 6(1):31-6. PubMed ID: 3410665
[TBL] [Abstract][Full Text] [Related]
17. Acute promyelocytic leukaemia in a patient treated with etoposide for Langerhans cell histiocytosis.
Matsuzaki A; Inamitsu T; Watanabe T; Ohga S; Ishii E; Nagotoshi Y; Tasaka H; Suda M; Ueda K
Br J Haematol; 1994 Apr; 86(4):887-9. PubMed ID: 7918090
[TBL] [Abstract][Full Text] [Related]
18. [Treatment results of Langerhans cell histiocytosis with LSH II protocol].
Mottl H; Ganevová M; Radvanská J; Chánová M; Smelhaus V; Kodet R; Mrhalová M; Tichý M
Cas Lek Cesk; 2005; 144(11):753-5. PubMed ID: 16335702
[TBL] [Abstract][Full Text] [Related]
19. [Histiocytosis syndrome in children].
Herlin T; Clausen N
Ugeskr Laeger; 1989 Jan; 151(4):225-8. PubMed ID: 2783792
[TBL] [Abstract][Full Text] [Related]
20. Treatment of adult Langerhans cell histiocytosis with etoposide.
Tsele E; Thomas DM; Chu AC
J Am Acad Dermatol; 1992 Jul; 27(1):61-4. PubMed ID: 1619078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
